焦虑障碍的治疗

被引：5

作者：

梅其一

机构：

[1] 江苏苏州市广济医院

来源：

临床精神医学杂志 | 2003年 / 04期

关键词：

焦虑障碍; 治疗;

D O I：

暂无

中图分类号：

R749.72 [];

学科分类号：

100205 ;

摘要：

我刊收到数篇关于文拉法辛缓释剂临床应用方面的稿件 ,现作为专题讨论于本期集中刊出 ,供读者参考。TopicforDiscussion :ClinicalapplicationofvenlafaxineXREditorialnote :SomepapersinclinicalapplicationofvenlafaxineXRhavebeenreceivedbyourjournal.Thesepaperswerecollectedinthisissueasaspecialtopicfordiscussionasreferencetoreaders.

引用

页码：238 / 239

页数：2

共 7 条

[1]

The National Depressive and Manic- Depressive Association consensus statement on the undertreatment of depression. Hirschfeld RM,Hirschfeld RM,Keller MB,et al. The Journal of The American Medical Association . 1997

[2]

Venlafaxine extended release(ER)in the treatment of generalised anxiety disorder: twenty - four - week placebo-controlled dose-ranging study. Allgulander C,Hackett D,Salinas E. British Journal of Psychiatry . 2001

[3]

Remission rates during treatment with venlafaxine or selective serltlnin reuptakeinhibitors. Thase ME,Entsuag AR,Rudolph RL. British Journal of Psychiatry . 2001

[4]

Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population. Druss BG,Schlesinger M,Allen HM Jr. American Journal of Psychiatry . 2001

[5]

Essential Psychopharmacology: Neuroscientific basis and practical applications. Stephen M,Stahl. . 2001

[6]

Neurotic disorders and the receipt of psychiatric treatment. Bebbington PE,Brugha TS,Meltzer H,et al. Psychological Medicine . 2000

[7]

Anxiety syndromes and their relationship to depressive illness. Fawcett J,Kravitz HM. Journal of Clinical Psychiatry . 1983

← 1 →